Bioasis (BTI.V) is a company that is delivering hope to patients suffering with neurological diseases and disorders. It is the Blood-Brain Barrier delivery company.
The Blood-Brain Barrier makes it difficult to deliver therapeutics to the brain. Enter Bioasis.
Bioasis has a patented delivery system called the xB3 platform technology. This enables the delivery of therapeutics such as enzymes, siRNA, antibodies, and other biologics and small molecules across the Blood-Brain Barrier and to the brain.
If you checked out our Investor Roundtable on Bioasis (BTI.V) you know that we are all fans. We covered the technicals, we covered the financials, and the recent news of a Japanese Patent Application. The one thing that may intimidate investors is the fact the investor presentation isn’t investor friendly. There’s a lot of science. If you can get through the 51 slides, you’ll be much more smarter than you were before reading their presentation. This might deter some to commit funds.
But when you through this all, you see the value in their patented delivery system. With good news and catalysts, the market will begin paying attention.
Above I have posted the daily chart of Bioasis (BTI.V). You can see I have drawn out three major support and resistance levels.
One of which we are testing currently. This $0.25 zone has been held since mid April of this year. Buyers are stepping in as you can see from the large wicks. This is a good zone to enter for a longer term hold. The opportunity cost being that you might miss out on other moves while Bioasis ranges. Biotech stocks tend to range, but when a catalyst comes, the pops are massive. We have been seeing massive biotech rallies recently.
If this level breaks due to no news or selling pressure, then $0.15 is the next support. That would be a very attractive price zone to buy or add to your position as it is previous record lows.
The breakout trigger I would watch for is a close above $0.30. Not only do we take out a technical swing level, but we would also cross over my moving averages. To the upside, there is some resistance at $0.425 I would watch.
In summary, Bioasis is a company that has long term upside potential. The technology and their patent adds value. The stock price is showing a nice basing pattern. It really is about the future catalysts and management now.